Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis ...

The US FDA has approved ruxolitinib (Opzelura) cream 1.5% for the short-term and noncontinuous chronic treatment of ...

If you or someone you love has eczema, you know treating it can be frustrating. It takes a lot of trial and error to f ...

Incyte (INCY) “announced that the FDA has approved Opzelura cream 1.5%, a topical Janus kinase inhibitor, for the short-term and non-continuous ...

Men's skin needs specific care. This article highlights common skin problems faced by men. Dryness, shaving irritation, dark circles, oily skin, and a ...

Adults who suffer from the common disorder are significantly more likely to express suicidal thoughts, concerning new ...

ZORYVE Allure Best of Beauty Product Image Allure Best of Beauty Breakthrough Award Winner ZORYVE (roflumilast) cream 0.15%; ...

Dry skin around the nose, a common issue worsened by environmental factors and skin conditions, can be effectively managed ...

July 24, 2025 – The FDA has approved a new treatment as the first and only skin cream for a specific type of hand eczema that affects about 1 in every 10 people globally. The cream, sold under the ...

Rosacea can cause redness, breakouts, and discomfort. Here, dermatologists share moisturizers that may help color-correct ...

Summer brings long days, outdoor fun, and plenty of sunshine—but for people living with chronic skin conditions like eczema, ...